DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,623 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $565,152 | -6.4% | 2,262 | -6.5% | 0.26% | -2.3% |
| Q1 2024 | $603,817 | -2.5% | 2,418 | -9.7% | 0.26% | -2.2% |
| Q4 2023 | $619,291 | -7.1% | 2,677 | -0.4% | 0.27% | -14.6% |
| Q3 2023 | $666,885 | -8.2% | 2,688 | -11.2% | 0.31% | -3.7% |
| Q2 2023 | $726,480 | +4.7% | 3,027 | +10.0% | 0.33% | +0.6% |
| Q1 2023 | $693,863 | +8.2% | 2,753 | +13.9% | 0.32% | +8.0% |
| Q4 2022 | $641,224 | +8.5% | 2,416 | +5.7% | 0.30% | -1.6% |
| Q3 2022 | $591,000 | +3.1% | 2,285 | +1.1% | 0.30% | +12.1% |
| Q2 2022 | $573,000 | -4.0% | 2,261 | +11.0% | 0.27% | +5.4% |
| Q1 2022 | $597,000 | +18.2% | 2,037 | +32.7% | 0.26% | +31.6% |
| Q4 2021 | $505,000 | +3266.7% | 1,535 | +2970.0% | 0.20% | +3166.7% |
| Q3 2021 | $15,000 | +15.4% | 50 | 0.0% | 0.01% | +20.0% |
| Q2 2021 | $13,000 | +18.2% | 50 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $11,000 | 0.0% | 50 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $11,000 | 0.0% | 50 | 0.0% | 0.01% | -16.7% |
| Q3 2020 | $11,000 | +22.2% | 50 | 0.0% | 0.01% | +20.0% |
| Q2 2020 | $9,000 | +28.6% | 50 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $7,000 | -41.7% | 50 | -33.3% | 0.00% | -33.3% |
| Q4 2019 | $12,000 | +9.1% | 75 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $11,000 | 0.0% | 75 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $11,000 | +10.0% | 75 | 0.0% | 0.01% | +20.0% |
| Q1 2019 | $10,000 | +25.0% | 75 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $8,000 | 0.0% | 75 | 0.0% | 0.01% | +25.0% |
| Q3 2018 | $8,000 | +14.3% | 75 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $7,000 | 0.0% | 75 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $7,000 | 0.0% | 75 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $7,000 | +16.7% | 75 | 0.0% | 0.00% | +33.3% |
| Q3 2017 | $6,000 | 0.0% | 75 | 0.0% | 0.00% | -25.0% |
| Q2 2017 | $6,000 | 0.0% | 75 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $6,000 | 0.0% | 75 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $6,000 | – | 75 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |